AI-washing – when AI hype becomes a litigation risk
Hogan Lovells Events
Why IP lawyers should care about the IRA
Join the Hogan Lovells Life Sciences & Health Care team and guest speaker Henry Hadad, Senior Vice President and Deputy General Counsel of Bristol Myers Squibb, for a discussion on the intellectual property impacts of the Inflation Reduction Act.
We will highlight key areas that the IP function at a pharma or biotech company of any size should consider, including strategies for investments in IP/innovation, license agreement strategies, patent prosecution considerations, what rights to prioritize (and not), litigation strategies, and more.
Contacts
Washington, D.C.
Senior Vice President and Deputy General Counsel, Bristol Myers Squibb
View more insights and analysis
